Seqirus Usa Revenue, Growth & Competitor Profile

DBA BIOCSL INC.

Company Profile & Annual Report for Seqirus Usa

Access the complete profile.

Seqirus Usa Fast Facts

Revenue	N/A    See Exact Annual Revenue
Employees	N/AExact Company Size
Primary Industry	325414 Biological Product Manufacturing
Address	25 Deforest Ave Ste 200 Summit, NJ 07901

Note: Revenues for privately held companies are statistical evaluations.


Seqirus Usa's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Seqirus Usa's annual revenues are N/A (see exact revenue data)
• What industry is the company in?
  • Seqirus Usa is classified as operating in the Biological Product Manufacturing industry, NAICS Code 325414.

Trademark Applications

Trademark applications show the products and services that Seqirus Usa is developing and marketing. Seqirus Usa doesn't have any recent trademark applications, indicating Seqirus Usa is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
SEQIRUS Vaccines; blood products, namely, immunoglobulins for medical or clinical use; serums for the treatment of influenza; antibodies; influenza vaccines; adjuvants and antigens; pharmaceutical preparations and substances for the treatment and/or prevention of blood or bleeding disorders, or diseases caused by bacteria and viruses; blood products, namely, blood plasma, and reagent blood cells; products derived from blood and products derived from recombinant DNA technology, namely, immunoglobulins, human albumin, blood clotting factors, plasma volume expanders, blood proteins for therapeutic use; serums, namely, anti-venoms; medicated serums for the treatment of blood or bleeding disorders; test kits, namely, invitro diagnostic reagent test kits for use in detecting cell mediated immune response; pharmaceutical preparations and substances, namely, RhD reagents for the detection of specific antigens or in blood typing; pharmaceutical preparations, namely, reagent red blood cells used to detect antibodies or IgG subtypes; pharmaceutical preparations, namely, monoclonal and polyclonal antibodies, and antibodies for use in the treatment of infectious diseases; pharmaceutical preparations, namely, reagents for medical/clinical use for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes	05/05/2015
ARMITAS Vaccines; blood products, namely, immunoglobulins for medical or clinical use; serums for the treatment of influenza; antibodies; influenza vaccines; adjuvants and antigens; pharmaceutical preparations and substances for the treatment and/or prevention of blood or bleeding disorders, or diseases caused by bacteria and viruses; blood products, namely, blood plasma, and reagent blood cells; products derived from blood and products derived from recombinant DNA technology, namely, immunoglobulins, human albumin, blood clotting factors, plasma volume expanders, blood proteins for therapeutic use; serums, namely, anti-venoms; medicated serums for the treatment of blood or bleeding disorders; test kits, namely, invitro diagnostic reagent test kits for use in detecting cell mediated immune response; pharmaceutical preparations and substances, namely, RhD reagents for the detection of specific antigens or in blood typing; pharmaceutical preparations, namely, reagent red blood cells used to detect antibodies or IgG subtypes; pharmaceutical preparations, namely, monoclonal and polyclonal antibodies, and antibodies for use in the treatment of infectious diseases; pharmaceutical preparations, namely, reagents for medical/clinical use for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes	05/05/2015
SPREAD WELLNESS Promoting public awareness of the need for influenza immunization and vaccination programs	04/22/2013

See all trademarks and details in the Full Report.

Market Share of Seqirus Usa's Largest Competitors

A competitive analysis shows these companies are in the same general field as Seqirus Usa, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
OXFORD BIOMEDICA SOLUTIONS	Bedford, MA	100
LAMPIRE BIOLOGICAL LABS	Pipersville, PA	85
MG BIOLOGICS	Ames, IA	39
BIO-SYNTHESIS	Lewisville, TX	37
GREEN MOUNTAIN ANTIBODIES	Burlington, VT	34
TRANS-INDIA PRODUCTS	Santa Rosa, CA	28
PMA MEDIA GROUP	Lehi, UT	25
BAILEY BARK MATERIALS	Nacogdoches, TX	24
1GLOBE HEALTH INSTITUTE	Norwood, MA	23

Nearby Competitors

These companies are similar in business line and location to Seqirus Usa. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
NOVARTIS	East Hanover, NJ	100
CELGENE	Summit, NJ	14
ALVOGEN GROUP	Morristown, NJ	13
EXELTIS USA	Florham Park, NJ	2
PHATHOM PHARMACEUTICALS	Florham Park, NJ	1
PHARMAHEALTH LABS	Morristown, NJ	1

Future Competition: Seqirus Usa's Fastest Growing Competitors

These companies are in the same general field as Seqirus Usa and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)